The physiology of the gut microbiota: barrier mechanisms, immune homeostasis, and the brain-gut axis

The relationship between the intestinal microbial population and the human organism constitutes a true mutualistic symbiosis. In exchange for immunological tolerance on the part of the host, the microbiota provides an essential contribution to the maintenance of physiological homeostasis through complex defensive, metabolic, and neuroendocrine functions.

The structural integrity of the gastrointestinal tract is ensured by an elaborate protective barrier consisting of the microbial biofilm, the mucous secretion, the lining epithelium, and the underlying lamina propria. Tight junction proteins (tight junctions), such as occludin and defensins, seal the intercellular space, preventing the luminal translocation of pathogens.

The indigenous microbiota limits exogenous bacterial colonization through multiple biochemical and cellular mechanisms:

• Survival and epithelial turnover: Strains such as Bifidobacterium and Lactobacillus protect enterocytes from pathogen-induced apoptosis (e.g., toxigenic strains of E. coli).
• Tissue organization: It modulates cell proliferation, supports the maintenance of tight junctions, and regulates the architecture of the vascular network that supplies the intestinal villi.
• Mucin-dependent secretion: Specific bacterial species induce the gene expression of mucins by the epithelium.

The centrality of the microbiota in the morphological development of the intestine is confirmed by germ-free animal models, which show a drastic reduction in villus thickness, a delay in enterocyte turnover, and severe alterations in mucosal architecture.

At the molecular level, immune surveillance is mediated by pattern recognition receptors (PRRs), in particular Toll-like Receptors (TLR) and NOD-like Receptors (NLR) expressed on enterocytes. These receptors identify bacterial molecules known as PAMPs (Pathogen-Associated Molecular Patterns). The tonic interaction between TLRs and molecules produced by the resident microbiota is essential for promoting epithelial repair following injurious insults and for maintaining immune tolerance.

Barrier homeostasis also relies on the activity of highly specialized cell populations:

Enterochromaffin cells act as true neuroendocrine transducers. They express receptors for neurotransmitters (serotonin, noradrenaline, acetylcholine, GABA) and TLRs. In pathological conditions, such as exposure to the cholera toxin produced by Vibrio cholerae, receptor binding increases intracellular levels of cyclic adenosine monophosphate (cAMP). This increase stimulates a massive release of serotonin, triggering the enteromotor secretory reflexes responsible for profuse diarrheal manifestations.

In addition to barrier functions, the microbiota represents a metabolically active organ capable of processing substrates that are not otherwise assimilated by humans. There is a direct interdependence between dietary intake and the microbial profile; changes in the lipid or fiber content of the diet induce compositional shifts within a few days.

The microbial population exerts a pronounced influence on the Enteric Nervous System (ENS) and the Autonomic Nervous System (ANS), which modulate intestinal motility, secretion, and vascular perfusion. Metabolites and soluble factors produced by different bacterial taxa act on intrinsic neuronal circuits: while Bifidobacterium bifidum and Lactobacillus acidophilus increase intestinal transit speed, specific strains of Escherichia induce a slowing of peristalsis.

Conversely, the ANS regulates the microbial composition by acting on the migrating motor complexes (MMCs) during fasting phases. Transit inhibition mediated by alterations in autonomic tone can cause luminal stasis and bacterial overgrowth (SIBO), altering the bioavailability of nutritional substrates, the endoluminal pH, and the physical properties of the mucosal biofilm.

The interaction between the digestive system and the central nervous system occurs through the complex microbiota-gut-brain axis (MGBA), a bidirectional circuit that integrates neuronal (vagus nerve, ENS, ANS), neuroendocrine (hypothalamic-pituitary-adrenal axis, HPA), and neuroimmune pathways.

In this system, bacterial metabolites (such as short-chain fatty acids, serotonin, and PAMPs) exert a paracrine action by activating TLR receptors located on the vagus nerve afferents and ENS neurons. The signals thus ascend along the vagal pathway to the Central Nervous System. In response to such stimuli or stress conditions, the brain activates the HPA axis, inducing the systemic secretion of cortisol and noradrenaline. These hormones react at the intestinal level, altering epithelial permeability, the immune response, and the composition of the microbiota itself.

Vagal transmission is primarily activated by serotonin released by enterochromaffin cells in response to mechanical or chemical stimuli. In the presence of inflammatory states or psychophysical stress, epithelial barrier hyperpermeability promotes the trans-mucosal passage of pro-inflammatory mediators and PAMPs, which stimulate sensory nerve endings, inducing neuroinflammation, altered stress response, and visceral hypersensitivity.

The intraluminal release of noradrenaline under conditions of stress or surgical trauma stimulates the expression of virulence factors in pathogens such as Pseudomonas aeruginosa and promotes the replication of Campylobacter jejuni, laying the pathophysiological foundations for the development of post-infectious functional gastrointestinal disorders (e.g., Irritable Bowel Syndrome - IBS).

The regulation of the serotonergic system represents one of the central aspects of the microbiota-gut-brain axis. Over 90% of the body's total serotonin is synthesized at the intestinal level by enterochromaffin cells. Genera such as Escherichia and Enterococcus possess metabolic pathways suitable for the direct production of 5-HT, while other strains stimulate endogenous epithelial synthesis through the production of short-chain fatty acids (SCFA).

Research conducted on germ-free animal models has shown that the complete absence of microbiota is associated with a paradoxical increase in serotonin and its metabolite (5-hydroxyindoleacetic acid) at the hippocampal level, together with high levels of free plasma tryptophan. Such evidence suggests the presence of a microbiota-driven humoral modulation pathway capable of influencing the development and plasticity of the central neurotransmitter pathways responsible for regulating mood tone and anxiety.

Bibliographic References

1. Sekirov, I., Russell, S. L., Antunes, L. C., & Finlay, B. B. (2010). Gut microbiota in health and disease. Physiological Reviews, 90(3), 859–904.
2. Yiu, J. H., Dorweiler, B., & Woo, C. W. (2017). Interaction between gut microbiota and Toll-like receptors: implications for inflammation and metabolic disorders. American Journal of Physiology-Endocrinology and Metabolism, 313(3), E297–E308.
3. Borre, Y. E., O'Keeffe, G. W., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2014). Microbiota and neurodevelopmental trajectories: role of maternal and early-life nutrition. Nutrition Reviews, 72(5), 333–351.
4. Giaroni, C., De Ponti, F., Cosentino, M., Lecchini, S., & Frigo, G. (1999). Organizing principles in the enteric nervous system. Progress in Neurobiology, 58(5), 425–460.
5. Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009). Principles and clinical implications of the brain-gut-enteric microbiota axis. Nature Reviews Gastroenterology & Hepatology, 6(5), 306–314.
6. Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015). Breaking down the barriers: the gut microbiome, intestinal permeability and depression. Frontiers in Cellular Neuroscience, 9, 392.
7. Reigstad, C. S., Salmonson, C. E., Rainey, J. F., 3rd, Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015). Gut microbes promote colonic serotonin production through short-chain fatty acids. FASEB Journal, 29(4), 1395–1403.
8. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013). The microbiome-gut-brain axis during early life regulates hippocampal serotonin metabolism in a sex-dependent manner. Molecular Psychiatry, 18(6), 666–673.